The Latest Breaking News from Vaccine

The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Insulet shares traded in a range of $260.13 to $266.73 on day volume of 200.86 thousand shares…

Pfizer Inc. and BioNTech SE asked the U.S. to authorize a new COVID-19 booster shot customized against the currently circulating COVID-19 variants as governments race to protect their populations against the ever-mutating virus.

Officials said the approach still offers good protection and will allow more people to access the jab

The smallpox vaccine has already been targeted at around 35,000 at risk people, mainly gay men and close contacts of cases including family members and healthcare workers

There are a significant number of babies and children at risk of polio, especially in areas of high deprivation and among Māori, with an outbreak a plane ride away, says Heather Battles

WASHINGTON — As the Biden administration scrambles to get a handle on the rapidly spreading monkeypox outbreak, its latest focus is getting vaccines to high-risk events, such as pride parades.

Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.

The testing of the vaccines have been completed at the Central Drug testing laboratories

UKHSA says studies suggest smaller doses generate ‘near-identical’ immune response

One site in Manchester and two in London will begin offering ‘fractional doses’ amid limited supplies.

British health authorities said they will begin offering eligible people just a fraction of the normal monkeypox vaccine dose to stretch supplies by about five times